Clinical evaluation of newly developed polysulfone membrane dialyzer (APS) in long term use

Japanese Journal of Artificial Organs

Volumn 26, Issue 4, 1997, Pages 858-864

  Sato, Y ^c   Ito, K ^a   Amemiya, H ^a   Kobayashi, T ^a   Uda, S ^c   Koiwa, F ^c   Nabeshima, K ^c   Kino, K ^c   Kinugasa, E ^c   Akizawa, T ^c   Ideura, T ^c   Tanigaki, K ^b  

^a SHOWA UNIVERSITY FUJIGAOKA HOSPITAL   (Japan)

^b Asahi Kasei Medical Co   (Japan)

^c NONE

Author keywords

APS; Biocompatibility; Lipid metabolism; Long term clinical effect

Indexed keywords

COMPLEMENT COMPONENT C3A; ELASTASE; GRANULOCYTE ENZYME; INTERLEUKIN 1BETA;

ARTICLE; ARTIFICIAL MEMBRANE; BIOCOMPATIBILITY; DIALYSIS MEMBRANE; HEMODIALYSIS; LIPID METABOLISM; MEMBRANE PERMEABILITY;

EID: 0030848249     PISSN: 03000818     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (10)

1. Blankestijn PJ, Vos PF, Rabelink TJ, van Rijn HJ. Jansen H, Koomans HA: High-flux dialysis membranes improve lipid profile in chronic hemodialysis patients. J Am Soc Nephrol 5: 1703, 1995